chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Skin discolouration
Clinical narrative: crying that her heel was hurting so bad; toes were less-colored, white, pale (different from other foot); This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pains in legs. Concomitant products included OXYCODONE HYDROCHLORIDE (OXYCONTIN) for an unknown indication.    On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)). The patient was treated with MAGNESIUM SULFATE (EPSOM SALTS [MAGNESIUM SULFATE]) (topical) on 22-Jan-2021 for Adverse event, at a dose of UNK dosage form (took epsom salt bath). At the time of the report, CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: face iitchy; Rash in his face and whole body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in his face and whole body) and PRURITUS (face iitchy ) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient had no known allergies before.     On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (Rash in his face and whole body) and PRURITUS (face iitchy ). At the time of the report, RASH (Rash in his face and whole body) and PRURITUS (face iitchy ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: large urticarial wheel at the site of the injection; Very itchy at injection site; Very red at the injetion site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE URTICARIA (large urticarial wheel at the site of the injection), VACCINATION SITE PRURITUS (Very itchy at injection site) and VACCINATION SITE ERYTHEMA (Very red at the injetion site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (large urticarial wheel at the site of the injection), VACCINATION SITE PRURITUS (Very itchy at injection site) and VACCINATION SITE ERYTHEMA (Very red at the injetion site). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE URTICARIA (large urticarial wheel at the site of the injection), VACCINATION SITE PRURITUS (Very itchy at injection site) and VACCINATION SITE ERYTHEMA (Very red at the injetion site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The large urticarial wheal at the site of injection had extended since 21-Jan-2021. It was about 4 inches in length and 1 inch in width and was very itchy. At the time of report it was somewhat itchy after a dose of Benadryl.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Feeling abnormal, Nausea
Clinical narrative: Temperature  was 101,temperature was recorded 101.8; arm tender; little swelling on neck; woke up feeling bad; had stomach upset; felt nauseous; vomited; felt chilled and shivering significantly; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (woke up feeling bad), TENDERNESS (arm tender), SWELLING (little swelling on neck), NAUSEA (felt nauseous) and VOMITING (vomited) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug hypersensitivity. Concomitant products included IRON for Iron supplementation.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced FEELING ABNORMAL (woke up feeling bad), NAUSEA (felt nauseous), VOMITING (vomited), CHILLS (felt chilled and shivering significantly) and ABDOMINAL DISCOMFORT (had stomach upset). On an unknown date, the patient experienced TENDERNESS (arm tender) and SWELLING (little swelling on neck). The patient was treated with PARACETAMOL (TYLENOL) on 20-Jan-2021 for Adverse event, at a dose of UNK dosage form and IBUPROFEN on 20-Jan-2021 for Adverse event, at a dose of UNK dosage form (on empty stomach). At the time of the report, FEELING ABNORMAL (woke up feeling bad), TENDERNESS (arm tender), SWELLING (little swelling on neck), NAUSEA (felt nauseous), VOMITING (vomited), CHILLS (felt chilled and shivering significantly) and ABDOMINAL DISCOMFORT (had stomach upset) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Body temperature: 99.1 f (High) 99.1 F. On 20-Jan-2021, Body temperature: 101 f (High) Around 4 PM , 101.8 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling, Tenderness, Vomiting
Clinical narrative: Temperature  was 101,temperature was recorded 101.8; arm tender; little swelling on neck; woke up feeling bad; had stomach upset; felt nauseous; vomited; felt chilled and shivering significantly; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (woke up feeling bad), TENDERNESS (arm tender), SWELLING (little swelling on neck), NAUSEA (felt nauseous) and VOMITING (vomited) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug hypersensitivity. Concomitant products included IRON for Iron supplementation.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced FEELING ABNORMAL (woke up feeling bad), NAUSEA (felt nauseous), VOMITING (vomited), CHILLS (felt chilled and shivering significantly) and ABDOMINAL DISCOMFORT (had stomach upset). On an unknown date, the patient experienced TENDERNESS (arm tender) and SWELLING (little swelling on neck). The patient was treated with PARACETAMOL (TYLENOL) on 20-Jan-2021 for Adverse event, at a dose of UNK dosage form and IBUPROFEN on 20-Jan-2021 for Adverse event, at a dose of UNK dosage form (on empty stomach). At the time of the report, FEELING ABNORMAL (woke up feeling bad), TENDERNESS (arm tender), SWELLING (little swelling on neck), NAUSEA (felt nauseous), VOMITING (vomited), CHILLS (felt chilled and shivering significantly) and ABDOMINAL DISCOMFORT (had stomach upset) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Body temperature: 99.1 f (High) 99.1 F. On 20-Jan-2021, Body temperature: 101 f (High) Around 4 PM , 101.8 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count, White blood cell count increased
Clinical narrative: Elevated white blood cells count; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of WHITE BLOOD CELL COUNT INCREASED (Elevated white blood cells count) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 21-Jan-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (Elevated white blood cells count). At the time of the report, WHITE BLOOD CELL COUNT INCREASED (Elevated white blood cells count) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, White blood cell count: elevated (High) elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mammogram, Myalgia, Pain in extremity, Paraesthesia
Clinical narrative: felt a little tingling after the injection; couldn't lift up her arm; arm was sore; massive pain in arm not just injection site, whole shoulder area; lots of vomiting; 2 lymph nodes in the left armpit; body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting) and LYMPHADENOPATHY (2 lymph nodes in the left armpit) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting), LYMPHADENOPATHY (2 lymph nodes in the left armpit) and MYALGIA (body aches). At the time of the report, PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting), LYMPHADENOPATHY (2 lymph nodes in the left armpit) and MYALGIA (body aches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: pending result (Inconclusive) pending result (to rule out breast cancer). On an unknown date, Ultrasound scan: lymph node (Inconclusive) lymph node. On an unknown date, X-ray: lymph node (Inconclusive) lymph node.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. After 5 hours, the patient had such massive pain in her arm, not just the injection site, it was the whole shoulder area. She couldn't lift up her arm to put on her bra; she was guessing it was because the lymph nodes swelling up so bad.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Vaccination site joint movement impairment, Vomiting, X-ray
Clinical narrative: felt a little tingling after the injection; couldn't lift up her arm; arm was sore; massive pain in arm not just injection site, whole shoulder area; lots of vomiting; 2 lymph nodes in the left armpit; body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting) and LYMPHADENOPATHY (2 lymph nodes in the left armpit) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting), LYMPHADENOPATHY (2 lymph nodes in the left armpit) and MYALGIA (body aches). At the time of the report, PARAESTHESIA (felt a little tingling after the injection), VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (couldn't lift up her arm), PAIN IN EXTREMITY (arm was sore; massive pain in arm not just injection site, whole shoulder area), VOMITING (lots of vomiting), LYMPHADENOPATHY (2 lymph nodes in the left armpit) and MYALGIA (body aches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: pending result (Inconclusive) pending result (to rule out breast cancer). On an unknown date, Ultrasound scan: lymph node (Inconclusive) lymph node. On an unknown date, X-ray: lymph node (Inconclusive) lymph node.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. After 5 hours, the patient had such massive pain in her arm, not just the injection site, it was the whole shoulder area. She couldn't lift up her arm to put on her bra; she was guessing it was because the lymph nodes swelling up so bad.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: it felt like it was a little lumpy at the injection site; itchy and red at injection site; itchy and red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (itchy and red at injection site), VACCINATION SITE PRURITUS (itchy and red at injection site) and VACCINATION SITE MASS (it felt like it was a little lumpy at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (itchy and red at injection site), VACCINATION SITE PRURITUS (itchy and red at injection site) and VACCINATION SITE MASS (it felt like it was a little lumpy at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (itchy and red at injection site), VACCINATION SITE PRURITUS (itchy and red at injection site) and VACCINATION SITE MASS (it felt like it was a little lumpy at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported. On 23-Jan-2021 feeling much better; it was faded a lot.   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Muscle spasms, Spinal pain
Clinical narrative: Muscle spasms on legs - "big time"; Spine pain; Joint pain; headaches; chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms on legs - "big time"), SPINAL PAIN (Spine pain), ARTHRALGIA (Joint pain), HEADACHE (headaches) and CHILLS (chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced MUSCLE SPASMS (Muscle spasms on legs - "big time"), SPINAL PAIN (Spine pain), ARTHRALGIA (Joint pain), HEADACHE (headaches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) in January 2021 for Adverse event, at a dose of UNK dosage form. On 15-Jan-2021, MUSCLE SPASMS (Muscle spasms on legs - "big time"), SPINAL PAIN (Spine pain), ARTHRALGIA (Joint pain), HEADACHE (headaches) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Symptoms lasted about 3 days and she only took Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: numbness in her fingers; numbness in her cheeks; weak; sore throat; exhausted; headache; muscle pain; some nausea; fever of 101.5; severe chills; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.5 (High) 101.5.         Concomitant medication was not reported. Treatment medication was not reported. The patient had vaccination at 08:40 AM and experienced the events at 08:50 AM on 21-Jan-2021.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Myalgia, Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: numbness in her fingers; numbness in her cheeks; weak; sore throat; exhausted; headache; muscle pain; some nausea; fever of 101.5; severe chills; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.5 (High) 101.5.         Concomitant medication was not reported. Treatment medication was not reported. The patient had vaccination at 08:40 AM and experienced the events at 08:50 AM on 21-Jan-2021.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: numbness in her fingers; numbness in her cheeks; weak; sore throat; exhausted; headache; muscle pain; some nausea; fever of 101.5; severe chills; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, HYPOAESTHESIA (numbness in her fingers), HYPOAESTHESIA (numbness in her cheeks), FATIGUE (exhausted), ASTHENIA (weak), HEADACHE (headache), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), NAUSEA (some nausea), PYREXIA (fever of 101.5), CHILLS (severe chills) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.5 (High) 101.5.         Concomitant medication was not reported. Treatment medication was not reported. The patient had vaccination at 08:40 AM and experienced the events at 08:50 AM on 21-Jan-2021.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: halo pink looking sore around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (halo pink looking sore around injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (halo pink looking sore around injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site erythema, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (halo pink looking sore around injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.   This case was linked to MOD-2021-013074 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Myalgia
Clinical narrative: Achy; Tiered; Joint Pain; Chills; Fever 103 F; muscle pain; Injection Site was a little Red; Injection Site was a little Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection Site was a little Red), VACCINATION SITE PAIN (Injection Site was a little Sore), MYALGIA (Achy), FATIGUE (Tiered) and ARTHRALGIA (Joint Pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (survived) in April 2020.    On 21-Jan-2021 at 11:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection Site was a little Red) and VACCINATION SITE PAIN (Injection Site was a little Sore). On 22-Jan-2021, the patient experienced MYALGIA (Achy), FATIGUE (Tiered), ARTHRALGIA (Joint Pain), CHILLS (Chills), PYREXIA (Fever 103 F) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) on 22-Jan-2021 for Fever, at a dose of 500 milligram three times a day. On 22-Jan-2021, VACCINATION SITE ERYTHEMA (Injection Site was a little Red) and VACCINATION SITE PAIN (Injection Site was a little Sore) had resolved. At the time of the report, MYALGIA (Achy), FATIGUE (Tiered), ARTHRALGIA (Joint Pain), CHILLS (Chills) and MYALGIA (muscle pain) had not resolved and PYREXIA (Fever 103 F) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 103 f (High) 103 F and 101.2 f (High) After taking Tylenol went down to 101.2 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: Achy; Tiered; Joint Pain; Chills; Fever 103 F; muscle pain; Injection Site was a little Red; Injection Site was a little Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection Site was a little Red), VACCINATION SITE PAIN (Injection Site was a little Sore), MYALGIA (Achy), FATIGUE (Tiered) and ARTHRALGIA (Joint Pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (survived) in April 2020.    On 21-Jan-2021 at 11:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection Site was a little Red) and VACCINATION SITE PAIN (Injection Site was a little Sore). On 22-Jan-2021, the patient experienced MYALGIA (Achy), FATIGUE (Tiered), ARTHRALGIA (Joint Pain), CHILLS (Chills), PYREXIA (Fever 103 F) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) on 22-Jan-2021 for Fever, at a dose of 500 milligram three times a day. On 22-Jan-2021, VACCINATION SITE ERYTHEMA (Injection Site was a little Red) and VACCINATION SITE PAIN (Injection Site was a little Sore) had resolved. At the time of the report, MYALGIA (Achy), FATIGUE (Tiered), ARTHRALGIA (Joint Pain), CHILLS (Chills) and MYALGIA (muscle pain) had not resolved and PYREXIA (Fever 103 F) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 103 f (High) 103 F and 101.2 f (High) After taking Tylenol went down to 101.2 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: swelling in the arm on the site of injection; there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.; there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.; there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE SWELLING (swelling in the arm on the site of injection), INJECTION SITE RASH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.), INJECTION SITE PRURITUS (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) and INJECTION SITE WARMTH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE SWELLING (swelling in the arm on the site of injection). 21-Jan-2021, the patient experienced INJECTION SITE RASH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.), INJECTION SITE PRURITUS (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) and INJECTION SITE WARMTH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.). At the time of the report, INJECTION SITE SWELLING (swelling in the arm on the site of injection), INJECTION SITE RASH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.), INJECTION SITE PRURITUS (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) and INJECTION SITE WARMTH (there is a rash, it's itchy, and it's a little bit uncomfortable. It's hot there as well.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication provided. no treatment given
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: red and warm reaction at the injection site; red and warm reaction at the injection site; mild soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (mild soreness at the injection site), INJECTION SITE ERYTHEMA (red and warm reaction at the injection site) and INJECTION SITE WARMTH (red and warm reaction at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history reported).    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced INJECTION SITE PAIN (mild soreness at the injection site). On 23-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red and warm reaction at the injection site) and INJECTION SITE WARMTH (red and warm reaction at the injection site). On 11-Jan-2021, INJECTION SITE PAIN (mild soreness at the injection site) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (red and warm reaction at the injection site) and INJECTION SITE WARMTH (red and warm reaction at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided no treatment taken
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Injection site swelling, Injection site urticaria, Tenderness
Clinical narrative: 2 roundish hives at injection site; tenderness; shoulder started to itch at injection site; red rash; swelling at injection site; sore arm/ pain; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (sore arm/ pain), INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash), INJECTION SITE SWELLING (swelling at injection site) and INJECTION SITE URTICARIA (2 roundish hives at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dermatitis due to metals since an unknown date. Concomitant products included ESTROGENS CONJUGATED (PREMARIN) for Dermatitis.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PAIN (sore arm/ pain). On 20-Jan-2021, the patient experienced INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash) and INJECTION SITE SWELLING (swelling at injection site). On 21-Jan-2021, the patient experienced TENDERNESS (tenderness). On an unknown date, the patient experienced INJECTION SITE URTICARIA (2 roundish hives at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash and Itch, at an unspecified dose and frequency. In January 2021, VACCINATION SITE PAIN (sore arm/ pain) outcome was unknown. On 22-Jan-2021, TENDERNESS (tenderness) had resolved. At the time of the report, INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash), INJECTION SITE SWELLING (swelling at injection site) and INJECTION SITE URTICARIA (2 roundish hives at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: 2 roundish hives at injection site; tenderness; shoulder started to itch at injection site; red rash; swelling at injection site; sore arm/ pain; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (sore arm/ pain), INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash), INJECTION SITE SWELLING (swelling at injection site) and INJECTION SITE URTICARIA (2 roundish hives at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dermatitis due to metals since an unknown date. Concomitant products included ESTROGENS CONJUGATED (PREMARIN) for Dermatitis.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PAIN (sore arm/ pain). On 20-Jan-2021, the patient experienced INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash) and INJECTION SITE SWELLING (swelling at injection site). On 21-Jan-2021, the patient experienced TENDERNESS (tenderness). On an unknown date, the patient experienced INJECTION SITE URTICARIA (2 roundish hives at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash and Itch, at an unspecified dose and frequency. In January 2021, VACCINATION SITE PAIN (sore arm/ pain) outcome was unknown. On 22-Jan-2021, TENDERNESS (tenderness) had resolved. At the time of the report, INJECTION SITE PRURITUS (shoulder started to itch at injection site), INJECTION SITE RASH (red rash), INJECTION SITE SWELLING (swelling at injection site) and INJECTION SITE URTICARIA (2 roundish hives at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Pyrexia
Clinical narrative: Positive covid test after 1st dose; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive covid test after 1st dose) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 12-Jan-2021, the patient experienced COVID-19 (Positive covid test after 1st dose). At the time of the report, COVID-19 (Positive covid test after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication and treatment information provided
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Hyperhidrosis, Influenza like illness
Clinical narrative: sweats; Coughs a lot; Feels like when you have the flu; No appetite; Big rash on the injection site; Chills; Itches a bit at injection site; Redness of the arm at injection site; rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite) and VACCINATION SITE RASH (Big rash on the injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included High cholesterol. Concurrent medical conditions included Seasonal allergy.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite), VACCINATION SITE RASH (Big rash on the injection site), CHILLS (Chills), VACCINATION SITE PRURITUS (Itches a bit at injection site), VACCINATION SITE ERYTHEMA (Redness of the arm at injection site) and VACCINATION SITE RASH (rash at injection site). At the time of the report, HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite), VACCINATION SITE RASH (Big rash on the injection site), CHILLS (Chills), VACCINATION SITE PRURITUS (Itches a bit at injection site), VACCINATION SITE ERYTHEMA (Redness of the arm at injection site) and VACCINATION SITE RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication provided patient has taken cough syrup but unknown
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: sweats; Coughs a lot; Feels like when you have the flu; No appetite; Big rash on the injection site; Chills; Itches a bit at injection site; Redness of the arm at injection site; rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite) and VACCINATION SITE RASH (Big rash on the injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included High cholesterol. Concurrent medical conditions included Seasonal allergy.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite), VACCINATION SITE RASH (Big rash on the injection site), CHILLS (Chills), VACCINATION SITE PRURITUS (Itches a bit at injection site), VACCINATION SITE ERYTHEMA (Redness of the arm at injection site) and VACCINATION SITE RASH (rash at injection site). At the time of the report, HYPERHIDROSIS (sweats), COUGH (Coughs a lot), INFLUENZA LIKE ILLNESS (Feels like when you have the flu), DECREASED APPETITE (No appetite), VACCINATION SITE RASH (Big rash on the injection site), CHILLS (Chills), VACCINATION SITE PRURITUS (Itches a bit at injection site), VACCINATION SITE ERYTHEMA (Redness of the arm at injection site) and VACCINATION SITE RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication provided patient has taken cough syrup but unknown
Sex: F
Vaccine: COVID19
Symptoms: Mass
Clinical narrative: bump in her arm; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication provided no treatment taken
Age: 41.0
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site urticaria
Clinical narrative: Urticaria at injection site; Injection site itchy; Injection site rash; Injection site redness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE URTICARIA (Urticaria at injection site), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE RASH (Injection site rash) and INJECTION SITE ERYTHEMA (Injection site redness) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (Urticaria at injection site), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE RASH (Injection site rash) and INJECTION SITE ERYTHEMA (Injection site redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) for Rash, Itchy and Urticaria, at an unspecified dose and frequency. At the time of the report, INJECTION SITE URTICARIA (Urticaria at injection site), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE RASH (Injection site rash) and INJECTION SITE ERYTHEMA (Injection site redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Dizziness
Clinical narrative: dizziness; Weakness; Anxious; This spontaneous case was reported by a non-health professional and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious). At the time of the report, DIZZINESS (dizziness), ASTHENIA (Weakness) and ANXIETY (Anxious) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication provided no treatment taken
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Pain of skin, Pruritus, Skin warm
Clinical narrative: red; hard; cellulitis at the injection site; hot; tender; itchy; This spontaneous case was reported by a patient and describes the occurrence of SKIN WARM (hot), PAIN OF SKIN (tender), PRURITUS (itchy), ERYTHEMA (red) and INDURATION (hard) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced SKIN WARM (hot), PAIN OF SKIN (tender) and PRURITUS (itchy). On 22-Jan-2021, the patient experienced ERYTHEMA (red), INDURATION (hard) and VACCINATION SITE CELLULITIS (cellulitis at the injection site). On 15-Jan-2021, PAIN OF SKIN (tender) had resolved. At the time of the report, SKIN WARM (hot), ERYTHEMA (red), INDURATION (hard) and VACCINATION SITE CELLULITIS (cellulitis at the injection site) outcome was unknown and PRURITUS (itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient went to urgent care after her symptoms returned and started worsening. They diagnosed her with cellulitis at the injection site and prescribed her Bactrim topical ointment and doxycycline oral.    Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: Additional information included further details regarding the events, and additional patient information.